ClinicalTrials.Veeva

Menu

Urell and Pregnancy

H

Hopital Foch

Status

Terminated

Conditions

Urinary Tract Infection (UTI)

Treatments

Dietary Supplement: URELL
Other: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT01818180
2009/19

Details and patient eligibility

About

Evaluation of the effect of URELL consumption on the occurrence of recurrent urinary tract infection (Acute cystitis, pyelonephritis and asymptomatic bacteriuria).

Enrollment

11 patients

Sex

Female

Ages

18 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pregnant woman in her 4th gestational month or more, having urinary tract infection.

Exclusion criteria

  • Pregnant woman with organic or functional urinary tract malformations
  • Diabetic patients
  • HIV positive

Trial design

11 participants in 2 patient groups, including a placebo group

Urell
Experimental group
Treatment:
Dietary Supplement: URELL
Placebo
Placebo Comparator group
Treatment:
Other: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems